每日居家血液透析与每周三次中心血液透析住院患者的比较。

Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.

机构信息

Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN.

Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN.

出版信息

Am J Kidney Dis. 2015 Jan;65(1):98-108. doi: 10.1053/j.ajkd.2014.06.015. Epub 2014 Jul 29.

Abstract

BACKGROUND

Cardiovascular disease is a common cause of hospitalization in dialysis patients. Daily hemodialysis improves some parameters of cardiovascular function, but whether it associates with lower hospitalization risk is unclear.

STUDY DESIGN

Observational cohort study using US Renal Data System data.

SETTING & PARTICIPANTS: Medicare-enrolled daily (5 or 6 sessions weekly) home hemodialysis (HHD) patients initiating NxStage System One use from January 1, 2006, through December 31, 2009, and contemporary thrice-weekly in-center hemodialysis patients, matched 5 to 1.

PREDICTOR

Daily HHD or thrice-weekly in-center hemodialysis.

OUTCOMES & MEASUREMENTS: All-cause and cause-specific hospital admissions, hospital readmissions, and hospital days assessed from Medicare Part A claims.

RESULTS

For 3,480 daily HHD and 17,400 thrice-weekly in-center hemodialysis patients in intention-to-treat analysis, the HR of all-cause admission for daily HHD versus in-center hemodialysis was 1.01 (95%CI, 0.98-1.03). Cause-specific admission HRs were 0.89 (95%CI, 0.86-0.93) for cardiovascular disease, 1.18 (95%CI, 1.13-1.23) for infection, 1.01 (95%CI, 0.93-1.09) for vascular access dysfunction, and 1.02 (95%CI, 0.99-1.06) for other morbidity. Regarding cardiovascular disease, first admission and readmission HRs for daily HHD versus in-center hemodialysis were 0.91 and 0.87, respectively. Regarding infection, first admission and readmission HRs were 1.35 and 1.03, respectively. Protective associations of daily HHD with heart failure and hypertensive disease were most pronounced, as were adverse associations of daily HHD with bacteremia/sepsis, cardiac infection, osteomyelitis, and vascular access infection.

LIMITATIONS

Results may be confounded by unmeasured factors, including vascular access type; information about dialysis frequency, duration, and dose was lacking; causes of admission may be misclassified; results may not apply to patients without Medicare coverage.

CONCLUSIONS

All-cause hospitalization risk was similar in daily HHD and thrice-weekly in-center hemodialysis patients. However, risk of cardiovascular-related admission was lower with daily HHD, and risk of infection-related admission was higher. More attention should be afforded to infection in HHD patients.

摘要

背景

心血管疾病是透析患者住院的常见原因。每日血液透析可改善心血管功能的某些参数,但它是否与较低的住院风险相关尚不清楚。

研究设计

使用美国肾脏数据系统数据的观察性队列研究。

研究场所和参与者

2006 年 1 月 1 日至 2009 年 12 月 31 日期间开始使用 NxStage 系统的 Medicare 登记的每日(每周 5 或 6 次)家庭血液透析(HHD)患者和同期每周三次的中心血液透析患者,按照 5:1 进行匹配。

预测因素

每日 HHD 或每周三次中心血液透析。

研究结果

在意向治疗分析中,共有 3480 名每日 HHD 和 17400 名每周三次中心血液透析患者,每日 HHD 与中心血液透析相比,全因入院的 HR 为 1.01(95%CI,0.98-1.03)。特定病因入院的 HR 为心血管疾病 0.89(95%CI,0.86-0.93)、感染 1.18(95%CI,1.13-1.23)、血管通路功能障碍 1.01(95%CI,0.93-1.09)和其他发病率 1.02(95%CI,0.99-1.06)。关于心血管疾病,每日 HHD 与中心血液透析相比,首次入院和再入院的 HR 分别为 0.91 和 0.87。关于感染,首次入院和再入院的 HR 分别为 1.35 和 1.03。每日 HHD 与心力衰竭和高血压疾病的保护关联最为明显,而与菌血症/败血症、心脏感染、骨髓炎和血管通路感染的不利关联也最为明显。

局限性

结果可能受到未测量因素的混杂,包括血管通路类型;缺乏关于透析频率、持续时间和剂量的信息;入院原因可能被错误分类;结果可能不适用于没有医疗保险的患者。

结论

每日 HHD 和每周三次中心血液透析患者的全因住院风险相似。然而,每日 HHD 患者心血管相关入院风险较低,感染相关入院风险较高。应更加关注 HHD 患者的感染问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索